Table of Contents Author Guidelines Submit a Manuscript
Journal of Ophthalmology
Volume 2017 (2017), Article ID 4052094, 12 pages
https://doi.org/10.1155/2017/4052094
Research Article

Tissue Distribution of trans-Resveratrol and Its Metabolites after Oral Administration in Human Eyes

1Department of Ophthalmology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, 1095 Jie-fang Road, Wuhan, Hubei Province, China
2Department of Ophthalmology, General Hospital of Wanbei Coal Group, Suzhou, Anhui 234000, China
3School of Chemistry and Engineering, Wuhan University of Technology, Wuhan 430070, China
4Eye Center, Second Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou 310000, China
5Shiley Eye Institute and Department of Ophthalmology, University of California, San Diego, La Jolla, San Diego, CA, USA

Correspondence should be addressed to Xufang Sun

Received 12 November 2016; Accepted 30 January 2017; Published 20 March 2017

Academic Editor: Vicente Zanon-Moreno

Copyright © 2017 Shuaishuai Wang et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. D. M. Goldberg, J. Yan, and G. J. Soleas, “Absorption of three wine-related polyphenols in three different matrices by healthy subjects,” Clinical Biochemistry, vol. 36, no. 1, pp. 79–87, 2003. View at Publisher · View at Google Scholar · View at Scopus
  2. Y. Wang, F. Catana, Y. Yang, R. Roderick, and R. B. van Breemen, “An LC-MS method for analyzing total resveratrol in grape juice, cranberry juice, and in wine,” Journal of Agricultural and Food Chemistry, vol. 50, no. 3, pp. 431–435, 2002. View at Publisher · View at Google Scholar · View at Scopus
  3. C. Bola, H. Bartlett, and F. Eperjesi, “Resveratrol and the eye: activity and molecular mechanisms,” Graefe's Archive for Clinical and Experimental Ophthalmology, vol. 252, no. 5, pp. 699–713, 2014. View at Publisher · View at Google Scholar · View at Scopus
  4. A. C. Cordova, L. S. Jackson, D. W. Berke-Schlessel, and B. E. Sumpio, “The cardiovascular protective effect of red wine,” Journal of the American College of Surgeons, vol. 200, no. 3, pp. 428–439, 2005. View at Publisher · View at Google Scholar · View at Scopus
  5. G. Kuhnle, J. P. Spencer, G. Chowrimootoo et al., “Resveratrol is absorbed in the small intestine as resveratrol glucuronide,” Biochemical and Biophysical Research Communications, vol. 272, no. 1, pp. 212–217, 2000. View at Publisher · View at Google Scholar · View at Scopus
  6. M. Vaz-da-Silva, A. I. Loureiro, A. Falcao et al., “Effect of food on the pharmacokinetic profile of trans-resveratrol,” International Journal of Clinical Pharmacology and Therapeutics, vol. 46, no. 11, pp. 564–570, 2008. View at Publisher · View at Google Scholar
  7. T. Walle, F. Hsieh, M. H. DeLegge, J. E. Oatis Jr, and U. K. Walle, “High absorption but very low bioavailability of oral resveratrol in humans,” Drug Metabolism and Disposition, vol. 32, no. 12, pp. 1377–1382, 2004. View at Publisher · View at Google Scholar · View at Scopus
  8. T. Nunes, L. Almeida, J. F. Rocha et al., “Pharmacokinetics of trans-resveratrol following repeated administration in healthy elderly and young subjects,” Journal of Clinical Pharmacology, vol. 49, no. 12, pp. 1477–1482, 2009. View at Publisher · View at Google Scholar · View at Scopus
  9. L. X. Wang, A. Heredia, H. Song et al., “Resveratrol glucuronides as the metabolites of resveratrol in humans: characterization, synthesis, and anti-HIV activity,” Journal of Pharmaceutical Sciences, vol. 93, no. 10, pp. 2448–2457, 2004. View at Publisher · View at Google Scholar · View at Scopus
  10. D. J. Boocock, G. E. Faust, K. R. Patel et al., “Phase I dose escalation pharmacokinetic study in healthy volunteers of resveratrol, a potential cancer chemopreventive agent,” Cancer Epidemiology, Biomarkers & Prevention, vol. 16, no. 6, pp. 1246–1252, 2007. View at Publisher · View at Google Scholar · View at Scopus
  11. M. E. Juan, J. Buenafuente, I. Casals, and J. M. Planas, “Plasmatic levels of trans-resveratrol in rats,” Food Research International, vol. 35, no. 2, pp. 195–199, 2002. View at Publisher · View at Google Scholar · View at Scopus
  12. H. Colom, I. Alfaras, M. Maijo, M. E. Juan, and J. M. Planas, “Population pharmacokinetic modeling of trans-resveratrol and its glucuronide and sulfate conjugates after oral and intravenous administration in rats,” Pharmaceutical Research, vol. 28, no. 7, pp. 1606–1621, 2011. View at Publisher · View at Google Scholar · View at Scopus
  13. A. Burkon and V. Somoza, “Quantification of free and protein-bound trans-resveratrol metabolites and identification of trans-resveratrol-C/O-conjugated diglucuronides - two novel resveratrol metabolites in human plasma,” Molecular Nutrition & Food Research, vol. 52, no. 5, pp. 549–557, 2008. View at Publisher · View at Google Scholar · View at Scopus
  14. S. P. Lin, P. M. Chu, S. Y. Tsai, M. H. Wu, and Y. C. Hou, “Pharmacokinetics and tissue distribution of resveratrol, emodin and their metabolites after intake of Polygonum cuspidatum in rats,” Journal of Ethnopharmacology, vol. 144, no. 3, pp. 671–676, 2012. View at Publisher · View at Google Scholar · View at Scopus
  15. E. Wenzel, T. Soldo, H. Erbersdobler, and V. Somoza, “Bioactivity and metabolism of trans-resveratrol orally administered to Wistar rats,” Molecular Nutrition & Food Research, vol. 49, no. 5, pp. 482–494, 2005. View at Publisher · View at Google Scholar · View at Scopus
  16. S. Richer, W. Stiles, L. Ulanski, D. Carroll, and C. Podella, “Observation of human retinal remodeling in octogenarians with a resveratrol based nutritional supplement,” Nutrients, vol. 5, no. 6, pp. 1989–2005, 2013. View at Publisher · View at Google Scholar · View at Scopus
  17. K. R. Patel, V. A. Brown, D. J. Jones et al., “Clinical pharmacology of resveratrol and its metabolites in colorectal cancer patients,” Cancer Research, vol. 70, no. 19, pp. 7392–7399, 2010. View at Publisher · View at Google Scholar · View at Scopus
  18. A. Schlachterman, F. Valle, K. M. Wall et al., “Combined resveratrol, quercetin, and catechin treatment reduces breast tumor growth in a nude mouse model,” Translational Oncology, vol. 1, no. 1, pp. 19–27, 2008. View at Publisher · View at Google Scholar · View at Scopus
  19. M. Herranz-López, S. Fernández-Arroyo, A. Pérez-Sanchez et al., “Synergism of plant-derived polyphenols in adipogenesis: perspectives and implications,” Phytomedicine International Journal of Phytotherapy & Phytopharmacology, vol. 19, no. 3–4, pp. 253–261, 2012. View at Publisher · View at Google Scholar · View at Scopus
  20. R. Toda, K. Kawazu, M. Oyabu, T. Miyazaki, and Y. Kiuchi, “Comparison of drug permeabilities across the blood-retinal barrier, blood-aqueous humor barrier, and blood-brain barrier,” Journal of Pharmaceutical Sciences, vol. 100, no. 9, pp. 3904–3911, 2011. View at Publisher · View at Google Scholar · View at Scopus
  21. S. Tsuboi, J. Taki-Noie, K. Emi, and R. Manabe, “Fluid dynamics in eyes with rhegmatogenous retinal detachments,” American Journal of Ophthalmology, vol. 99, no. 6, pp. 673–676, 1985. View at Publisher · View at Google Scholar
  22. H. L. Cantrill and J. E. Pederson, “Experimental retinal detachment III. Vitreous fluorophotometry,” Archives of Ophthalmology, vol. 100, no. 11, pp. 1810–1813, 1982. View at Google Scholar
  23. B. C. Little and V. M. Ambrose, “Blood-aqueous barrier breakdown associated with rhegmatogenous retinal detachment,” Eye, vol. 5, no. Pt 1, pp. 56–62, 1991. View at Publisher · View at Google Scholar · View at Scopus
  24. A. Abeng’ozar-Vela, M. Calonge, M. E. Stern, M. J. González-García, and A. Enríquez-De-Salamanca, “Quercetin and resveratrol decrease the inflammatory and oxidative responses in human ocular surface epithelial cells,” Investigative Ophthalmology & Visual Science, vol. 56, no. 4, pp. 2709–2719, 2015. View at Publisher · View at Google Scholar · View at Scopus
  25. J. A. Baur and D. A. Sinclair, “Therapeutic potential of resveratrol: the in vivo evidence,” Nature Reviews. Drug Discovery, vol. 5, no. 6, pp. 493–506, 2006. View at Publisher · View at Google Scholar · View at Scopus
  26. V. P. Pearce, J. Sherrell, Z. Lou, L. Kopelovich, W. E. Wright, and J. W. Shay, “Immortalization of epithelial progenitor cells mediated by resveratrol,” Oncogene, vol. 27, no. 17, pp. 2365–2374, 2008. View at Publisher · View at Google Scholar · View at Scopus
  27. K. A. Waite, M. R. Sinden, and C. Eng, “Phytoestrogen exposure elevates PTEN levels,” Human Molecular Genetics, vol. 14, no. 11, pp. 1457–1463, 2005. View at Publisher · View at Google Scholar · View at Scopus
  28. Y. Dobrydneva, R. L. Williams, and P. F. Blackmore, “trans-Resveratrol inhibits calcium influx in thrombin-stimulated human platelets,” British Journal of Pharmacology, vol. 128, no. 1, pp. 149–157, 1999. View at Publisher · View at Google Scholar · View at Scopus
  29. X. Vitrac, A. Desmoulière, B. Brouillaud et al., “Distribution of [14C]-trans-resveratrol, a cancer chemopreventive polyphenol, in mouse tissues after oral administration,” Life Sciences, vol. 72, no. 20, pp. 2219–2233, 2003. View at Publisher · View at Google Scholar · View at Scopus
  30. D. Rokicki, R. Zdanowski, S. Lewicki et al., “Inhibition of proliferation, migration and invasiveness of endothelial murine cells culture induced by resveratrol,” Central-European Journal of Immunology, vol. 39, no. 4, pp. 449–454, 2014. View at Publisher · View at Google Scholar · View at Scopus
  31. S. Balaiya, R. K. Murthy, and K. V. Chalam, “Resveratrol inhibits proliferation of hypoxic choroidal vascular endothelial cells,” Molecular Vision, vol. 19, no. 4, pp. 2385–2392, 2012. View at Google Scholar
  32. H. M. Wang, G. X. Li, H. S. Zheng, and X. Z. Wu, “Protective effect of resveratrol on lens epithelial cell apoptosis in diabetic cataract rat,” Asian Pacific Journal of Tropical Medicine, vol. 8, no. 2, pp. 153–156, 2015. View at Publisher · View at Google Scholar · View at Scopus
  33. C. N. Nagineni, R. Raju, K. K. Nagineni et al., “Resveratrol suppresses expression of VEGF by human retinal pigment epithelial cells: potential nutraceutical for age-related macular degeneration,” Aging and Disease., vol. 5, no. 2, pp. 88–100, 2014. View at Publisher · View at Google Scholar
  34. S. Richer, S. Patel, S. Sockanathan, L. J. Ulanski, L. Miller, and C. Podella, “Resveratrol based oral nutritional supplement produces long-term beneficial effects on structure and visual function in human patients,” Nutrients., vol. 6, no. 10, pp. 4404–4420, 2014. View at Publisher · View at Google Scholar · View at Scopus
  35. S. Wang, N. Moonasar, and X. XiaoT. Yin, R. N. Weinreb, and X. Sun, “Effect of resveratrol-based nutritional supplement on choroidal thickness: a pilot study,” Current Eye Research, vol. 41, no. 10, pp. 1339–1345, 2016. View at Publisher · View at Google Scholar · View at Scopus
  36. C. De Santi, A. Pietrabissa, R. Spisni, F. Mosca, and G. M. Pacifici, “Sulphation of resveratrol, a natural product present in grapes and wine, in the human liver and duodenum,” Xenobiotica, vol. 30, no. 6, pp. 609–617, 2000. View at Publisher · View at Google Scholar
  37. J. F. Marier, P. Vachon, A. Gritsas, J. Zhang, J. P. Moreau, and M. P. Ducharme, “Metabolism and disposition of resveratrol in rats: extent of absorption, glucuronidation, and enterohepatic recirculation evidenced by a linked-rat model,” The Journal of Pharmacology and Experimental Therapeutics, vol. 302, no. 1, pp. 369–373, 2002. View at Publisher · View at Google Scholar · View at Scopus
  38. M. Asensi, I. Medina, A. Ortega, J. Carretero, M. C. Baño, and E. Obrador, “Inhibition of cancer growth by resveratrol is related to its low bioavailability,” Free Radical Biology & Medicine, vol. 33, no. 3, pp. 387–398, 2002. View at Publisher · View at Google Scholar · View at Scopus
  39. D. Wang, Y. Xu, and W. Liu, “Tissue distribution and excretion of resveratrol in rat after oral administration of Polygonum cuspidatum extract (PCE),” Phytomedicine, vol. 15, no. 10, pp. 859–866, 2008. View at Publisher · View at Google Scholar · View at Scopus
  40. K. Schueller, M. Pignitter, and V. Somoza, “Sulfated and glucuronated trans-resveratrol metabolites regulate chemokines and Sirtuin-1 expression in U-937 macrophages,” Journal of Agricultural and Food Chemistry, vol. 63, no. 29, pp. 6535–6545, 2015. View at Publisher · View at Google Scholar · View at Scopus
  41. K. K. Abuamero, A. A. Kondkar, and K. V. Chalam, “Resveratrol and ophthalmic diseases,” Nutrients, vol. 8, no. 4, pp. 200–210, 2016. View at Publisher · View at Google Scholar · View at Scopus
  42. C. Luna, G. Li, P. B. Liton et al., “Resveratrol prevents the expression of glaucoma markers induced by chronic oxidative stress in trabecular meshwork cells,” Food and Chemical Toxicology, vol. 47, no. 1, pp. 198–120, 2009. View at Publisher · View at Google Scholar · View at Scopus
  43. P. R. van Ginkel, S. R. Darjatmoko, D. Sareen et al., “Resveratrol inhibits uveal melanoma tumor growth via early mito-chondrial dysfunction,” Investigative Ophthalmology & Visual Science, vol. 49, no. 4, pp. 1299–1306, 2008. View at Publisher · View at Google Scholar · View at Scopus